Related Experiment Videos
Radiation therapy: a primary treatment modality for seminoma
The Urologic Clinics of North America
|October 1, 1980
Summary
Seminomas are radiosensitive cancers. Treatment for seminoma depends on the stage, with radiation therapy for early stages and chemotherapy for advanced stages, while serum tumor markers aid diagnosis.
Area of Science:
- Oncology
- Radiation Oncology
- Medical Oncology
Background:
- Seminomas are a type of germ cell tumor.
- Treatment strategies for seminoma have evolved.
- Accurate staging is crucial for effective management.
Purpose of the Study:
- To outline current treatment guidelines for seminoma based on disease stage.
- To highlight the role of radiation therapy, chemotherapy, and surgery.
- To emphasize the importance of serum tumor markers in diagnosis and staging.
Main Methods:
- Review of existing literature and clinical guidelines for seminoma management.
- Analysis of treatment responses based on disease stage and tumor markers.
- Correlation of diagnostic modalities with therapeutic outcomes.
Main Results:
- Stage I seminoma: Radiation therapy to para-aortic, pelvic, and inguinal nodes.
- Stage II seminoma: Radiation therapy (including mediastinum/supraclavicular nodes) for most; surgery/chemotherapy for bulky disease or elevated human chorionic gonadotropin (hCG).
- Stage III seminoma: Initial chemotherapy. Elevated alpha-fetoprotein (AFP) indicates nonseminomatous germ cell neoplasm.
Conclusions:
- Seminomas are radiosensitive, guiding radiation therapy use in early stages.
- Chemotherapy is the primary treatment for Stage III seminoma.
- Serum tumor markers like AFP and hCG are vital for diagnosis, staging, and treatment decisions in germ cell tumors.